2002
DOI: 10.1046/j.1440-1746.2002.02703.x
|View full text |Cite
|
Sign up to set email alerts
|

Decreased production of insulin‐like growth factor‐binding protein (IGFBP)‐6 by transfection of colon cancer cells with an antisense IGFBP‐6 cDNA construct leads to stimulation of cell proliferation

Abstract: : Our findings are consistent with the hypothesis that IGFBP-6 inhibits cell growth by binding to endogenously produced IGF-II, thereby preventing IGF-II from interacting with the IGF-I receptor to stimulate cellular proliferation by an autocrine mechanism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…IGFBP-6 binds and inhibits the activity of IGF-II cell proliferation by preventing IGF-II interaction with the IGF-I receptor (36). The complete degradation of IGFBP-6 into multiple fragments by MMP-2 should disrupt IGF-II binding and so increase IGF-II bioavailability.…”
Section: Discussionmentioning
confidence: 99%
“…IGFBP-6 binds and inhibits the activity of IGF-II cell proliferation by preventing IGF-II interaction with the IGF-I receptor (36). The complete degradation of IGFBP-6 into multiple fragments by MMP-2 should disrupt IGF-II binding and so increase IGF-II bioavailability.…”
Section: Discussionmentioning
confidence: 99%
“…With TCDD-induced expression of IGFBP-6, a high degree of IGFBP-6 elevation appeared to enhance apoptosis, whereas a reduction of IGFBP-6 inhibited TCDD from inducing apoptosis in thymoma cells (53). Inactivating the expression of IGFBP-6 in colon cancer cells resulted in a gain of cell proliferation, suggesting that IGFBP-6 may be inhibitory for cell growth (43). Whether IGFBP-6 mediates growth arrest or apoptosis induced by H 2 O 2 treatment remains to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Together, IGFBP-4, -5 and -6 constitute less than 25% of the total IGF-binding capacity in serum and they appear to have preference for IGF-II [3]. In vitro studies suggest that IGF-I mediated actions are generally inhibited by IGFBP-4 and -6, but potentiated by IGFBP-5 [2,80]. Accordingly, serum free IGF-I has been reported to correlate inversely with IGFBP-4 and positively with IGFBP-5, whereas the relationship between free IGF-I and IGFBP-6 is less settled [81,82].…”
Section: The Regulation Of Free and Total Igf-i: Effects Of Gh Insulmentioning
confidence: 99%